References
- Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins: basic science and product development. J Pharm Pharmacol 2010;62:1607–21
- Siddalingappa B, Nekkanti V, Betageri GV. Insoluble drug delivery technologies: review of health benefits and business potentials. OA Drug Design Deliv 2013;1:1–5
- Basavaraj S, Betageri GV. Can formulation and drug delivery reduce attrition during drug discovery and development – review of feasibility, benefits and challenges. Acta Pharma Sin B 2014;4:3–17
- Verma S, Singh SK, Verma PRP, Ahsan MN. Formulation by design of felodipine loaded liquid and solid self nanoemulsifying drug delivery systems using Box–Behnken design. Drug Dev Ind Pharm 2014;40:1358–70
- Lee TW-Y, Boersen NA, Yang G, Hui H-W. Evaluation of different screening methods to understand the dissolution behaviors of amorphous solid dispersions. Drug Dev Ind Pharm 2014;40:1072–83
- Chowdary K, Rao SS. Investigation of dissolution enhancement of itraconazole by solid dispersion in super disintegrants. Drug Dev Ind Pharm 2000;26:1207–11
- Davis ME, Brewster ME. Cyclodextrin-based pharmaceutics: past, present and future. Nat Rev Drug Discov 2004;3:1023–35
- Del Valle EMM. Cyclodextrins and their uses: a review. Process Biochem 2004;39:1033–46
- Basavaraj S, Sihorkar V, Shantha KT, et al. Bioavailability enhancement of poorly water soluble and weakly acidic new chemical entity with 2-hydroxy propyl-β-cyclodextrin: selection of meglumine, a polyhydroxy base, as a novel ternary component. Pharm Dev Technol 2006;11:443–51
- Shanthakumar T, Prakash S, Basavaraj, et al. Comparative pharmacokinetic data of DRF-4367 using nanosuspension and HP-β-CD formulation. In: Proceedings of the International Symposium on Advances in Technology and Business Potential of New Drug Delivery Systems, Mumbai; 2004:75
- Wang Q, Li S, Che X, et al. Dissolution improvement and stabilization of ibuprofen by co-grinding in a β-cyclodextrin ground complex. Asian J Pharm Sci 2010;5:188–93
- Singh SK, Srinivasan K, Singare DS, et al. Formulation of ternary complexes of glyburide with hydroxypropyl-β-cyclodextrin and other solubilizing agents and their effect on release behavior of glyburide in aqueous and buffered media at different agitation speeds. Drug Dev Ind Pharm 2012;38:1328–36
- Parikh DM. Handbook of pharmaceutical granulation technology. Boca Raton: CRC Press; 1997
- FMC Biopolymer. Available form http://www.fmcbiopolymer.com/Pharmaceutical/Products/Avicelforsoliddoseforms.aspx [last accessed 28 Jan 2014]
- Mura P, Faucci MT, Bettinetti GP. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-β-cyclodextrin. Eur J Pharm Sci 2001;13:187–94
- Li P, Zhao L, Yalkowsky SH. Combined effect of cosolvent and cyclodextrin on solubilization of nonpolar drugs. J Pharm Sci 1999;88:1107–11
- Yang G, Jain N, Yalkowsky SH. Combined effect of SLS and (SBE)7M-β-CD on the solubilization of NSC-639829. Int J Pharm 2004;269:141–8
- Lechat FL, Wouessidjewe D, Herrenknecht C, Duchěne D. Preparation and stability of iodine/α-cyclodextrin inclusion complex. Drug Dev Ind Pharm 1992;18:1853–63
- Cirri M, Maestrelli F, Furlanetto S, Mura P. Solid-state characterization of glyburide-cyclodextrin co-ground products. J Therm Anal Calorim 2004;77:413–22
- Holvoet C, Vander Heyden Y, Plaizier-Vercammen J. Influence of preparation method on itraconazole oral solutions using cyclodextrins as complexing agents. Pharmazie 2007;62:510–14
- Sporanox Oral Solution. Available from: http://www.rxlist.com/sporanox-oral-solution-drug.htm [last accessed 27 Jan 2015]
- Ridhurkar DN, Ansari KA, Kumar D, et al. Inclusion complex of aprepitant with cyclodextrin: evaluation of physico-chemical and pharmacokinetic properties. Drug Dev Ind Pharm 2013;39:1783–92
- Samprasit, W, Rojanarata T, Akkaramongkolporn P, et al. Improvement of drug loading onto ion exchange resin by cyclodextrin inclusion complex. Drug Dev Ind Pharm 2013;39:1672–80
- Guo B, Zhong S, Li N, et al. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin. Drug Dev Ind Pharm 2013;39:1638–43
- Aloisio C, Gomes de Oliveira A, Longhi M. Characterization, inclusion mode, phase-solubility and in vitro release studies of inclusion binary complexes with cyclodextrins and meglumine using sulfamerazine as model drug. Drug Dev Ind Pharm 2014;40:919–28
- Deschamps B, Musaji N, Gillespie JA. Food effect on the bioavailability of two distinct formulations of megestrol acetate oral suspension. Int J Nanomed 2009;4:185–92